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Objective: This study investigated late outcomes (mortality, reoperations) and their associated predictors after operations
for acute type A aortic dissection. The role catheter-based and hybrid interventions is discussed.
Methods: All hospital survivors operated on for acute type A aortic dissection from 1990 through 2009 were reviewed,
with cross-sectional follow-up. Mortality (overall and aortic) and freedom from reoperations (proximal and distal) were
estimated using actuarial methods. Preoperative, intraoperative, and postoperative variables (n[ 44) associated with late
outcomes were analyzed with univariable and multivariable (Cox) statistical methods.
Results: Of 360 operated-on patients, 291 hospital survivors (81%) were monitored for a median of 5.5 years (1864
patient-years). Total late mortality was 30% (n [ 86), with estimated (standard error) survival of 82% (3%), 64% (4%),
and 48% (6%) at 5, 10, and 15 years, respectively. Aortic events accounted for at least 27% (up to 42% including unknown
causes) of late deaths. In Cox analysis, variables independently related (hazard ratios [95% conﬁdence limits]) to late
mortality were increased age (1.6 per 10 years [1.3, 2.0]), earlier operation (<2005; 2.3 [1.2, 4.6]), permanent neurologic
damage (2.6 [1.6, 4.2]), and respiratory insufﬁciency (3.4 [1.8, 6.4]). Thirty-four patients underwent 46 reoperations,
21 on the proximal and 25 on the distal aorta, up to 19 years after the primary operation; respective in-hospital reo-
perative mortality was 14% and 12%. Estimated freedom (standard error) from aortic reoperation was 95% (2%), 87%
(4%), and 61% (5%) at 5, 10, and 15 years, respectively. In multivariable Cox analysis (hazard ratios [95% conﬁdence
limits]), use of surgical adhesive at the primary operation (4.2 [1.6, 11]) and temporary neurologic damage (3.2l [1.2,
8.9]) were independently related to proximal reoperation, and DeBakey type I dissection (10.5 [1.4, 80]) was related to
late distal reoperation. Catheter-based (endovascular, percutaneous) or hybrid procedures were not used in any patients
but could have been used in up to 74% of reoperations, including in four of six of those that resulted in in-hospital death
and putatively in 10 of 17 patients who sustained lethal aortic events without reoperation.
Conclusions: Despite close follow-up, aortic-related death after a successful operation for acute type A aortic dissection is
prevalent, and overall mortality remains substantial. Reoperations are not uncommon, may be indicated very late as well as
repeatedly in the same patient, and are associated with a signiﬁcant mortality. Increased use of applicable but seemingly
under-used catheter-based or hybrid treatment approaches could beneﬁt this growing patient population by offering repeat
intervention tomore patients and as substitute for reoperative open surgery in selected cases. (J Vasc Surg 2013;58:333-9.)Study and analysis of long-term results in operated-on
acute type A aortic dissection survivors are important
because (1) the long-term mortality rate is higher
than that of the normal population1,2; (2) despite close
follow-up, aortic events (rupture, repeat dissection) cause
a substantial proportion of late deaths1,3,4; (3) mortality
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as a benchmark fordand help establish the role ofd
catheter-based (percutaneous, endovascular) and hybrid
treatment modalities currently applicable to essentially all
aortic segments.
Therefore, it also remains important to identify predic-
tors of late death and late aortic reoperation as well as
causes of late death, eventually to reduce as far as possible
the occurrence of adverse outcomes. In this study, long-
term survival, cause of death, and reoperations in a large,
contemporary cohort of patients surviving surgery of acute
type A aortic dissection were analyzed, emphasizing their
implications for catheter-based or hybrid interventions.
METHODS
This study was approved by the regional Research
Ethics Committee (Ref No. 2008/1771-31), which
waived the need for individual informed consent.
Patients. From January 1, 1990, through December
31, 2009, 360 consecutive patients were operated on for
acute type A aortic dissection. In-hospital mortality was333
Table I. Preoperative, intraoperative, and postoperative
variables in surgical hospital survivors and nonsurvivors
Variablea
Hospital
Survivors
(n ¼ 291)
Nonsurvivors
(n ¼ 69)
Preoperative
Sex
Male 215 (74) 50 (72)
Female 76 (26) 19 (28)
Age, years 59 (58, 60) 61 (59, 65)
Marfan syndrome 7 (2.4) 1 (1.4)
Family history 14 (4.8) 4 (5.8)
COPD 14 (4.8) 5 (7.2)
Diabetes 2 (0.69) 1 (1.4)
Hypertension 198 (68) 45 (65)
Smoking 72 (25) 8 (12)
Obesity 22 (7.6) 9 (13)
CVI history 7 (2.4) 3 (4.3)
Redo operation 9 (3.1) 3 (4.3)
DeBakey type I 165 (57) 47 (68)
Early era (<2004) 176 (60) 52 (75)
Aortic regurgitation 155 (53) 34 (49)
Tamponade 95 (33) 31 (45)
Penn class
Aa 189 (65) 30 (43)
Ab 39 (13) 12 (17)
Ac 8 (16) 15 (22)
Abc 15 (5.2) 12 (17)
Intraoperative
Supracoronary graft 201 (69) 43 (73)
Valve þ graft 4 (1.4) 2 (2.9)
Composite graft 86 (30) 23 (33)
Aortic valve resuspension 76 (26) 9 (13)
HCA 249 (86) 64 (93)
Hemiarch replacement 48 (16) 10 (14)
Total arch replacement 11 (3.8) 7 (10)
Coronary artery bypass 24 (8.2) 18 (26)
Surgical adhesive (GRF) 92 (32) 23 (33)
Cerebral perfusion 186 (64) 43 (62)
Postoperative
Reoperation for bleeding 49 (17) 15 (22)
Reoperation for infection 6 (2.1) 0 (0)
Renal failure 17 (5.8) 8 (12)
Respiratory failure 21 (7.2) 7 (10)
Neurologic damage
Temporary 29 (10) 2 (2.9)
Permanent 38 (13) 26 (38)
CL, Conﬁdence limit; COPD, chronic obstructive pulmonary disease; CVI,
cerebrovascular insult; GRF, gelatin-resorcinol-formaldehyde; HCA, hypo-
thermic circulatory arrest.
a
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334 Olsson et al August 201369 of 360 (19%), resulting in 291 surgical survivors avail-
able for long-term follow-up. Clinical characteristics of the
hospital survivors and nonsurvivors are summarized in
Table I. Cross-sectional follow-up was performed in
October 2010, with additional data on reoperative proce-
dures procured in May 2011.
Procedures. Surgical procedures, anesthesia, and
perfusion techniques have been described in detail previ-
ously.6 Brieﬂy, prosthetic replacement of the ascending
aorta was performed, combined proximally with aortic
valve preservation (valve untouched, resuspended, or
reimplanted) or replacement (separate prosthetic valve
or as a composite graft with coronary artery reimplanta-
tion). Distally, procedures were performed during aortic
cross-clamping or with open distal anastomosis requiring
hypothermic circulatory arrest. Hemiarch or total arch
replacement was performed selectively. For augmented
cerebral protection, retrograde antegrade cerebral perfu-
sion was used selectively.
Outcomes. Variables, including 19 preoperative, 17
intraoperative, and eight postoperative variables, and deﬁ-
nitions used for statistical univariate and multivariable anal-
ysis are detailed in the Appendix (online only). The speciﬁc
outcomes studied were overall mortality, aortic-related
mortality, and proximal or distal aortic reoperation (deﬁ-
nitions detailed in the Appendix, online only). Follow-up
included in-house regular (annual and biannual)
computed tomography scans of the entire aorta and clinical
visits as motivated in the majority of patients.
Statistical analysis. Categoric variables are presented
as numbers and percentages. Continuous variables are pre-
sented as means with 95% conﬁdence limits (CLs). Group
comparisons were performed using the Student t-test for
continuous variables and the two-sided c2 test or Fisher
exact test for categoric variables. Survival estimates were
calculated with 95% CLs using actuarial (Kaplan-Meier)
methods. Survival estimates were group-wise compared
using the log-rank test. Variables associated with survival in
univariate analysis (log-rank P < .10) were included in
multivariable Cox regression analysis to identify variables
independently related to outcome (P < .05) using a back-
ward stepwise approach to variable selection. Results of
Cox regression are presented as hazard ratio (HR) with
95% CL. Statistical analysis was performed using STATA
11.1 software (StataCorp LP, College Station, Tex).Categoric variables are shown as number (%) and continuous variables as
mean (95% CLs).RESULTS
Long-term survival. Survival status follow-up was
99% complete. Cumulative follow-up was 1864 patient-
years, and median (95% CL) survival was 5.5 years (4.8,
6.2; range, 10 days-20.5 years). Fig 1 delineates the overall
long-term outcomes for mortality and reoperations.
During the entire follow-up, late death occurred in 86 of
291 (30%), corresponding to a linearized attrition rate of
5% per patient-year. Estimated Kaplan-Meier survival
(standard error) at 1, 5, 10, and 15 years was 94% (1%),
82% (2%), 64% (4%), and 48 (6%), respectively (Fig 2).Causes of late death. As summarized in Table II,
aortic and cardiac events were the dominating causes of late
death. Speciﬁcally, univariate analysis showed family history
(P ¼ .022) and lower age (#39 years; P ¼ .0069) were risk
factors for aortic cause of late death. In multivariable
analysis, lower age remained independently related to
increased risk of aortic late death; the HR (95% CL) for
each decade of increased age >39 years was 0.60 (0.39,
0.90; P ¼ .011). Seventeen patients died from an aortic
cause without a direct relation to an aortic reoperation.
Fig 1. Flow chart shows overall patient population and follow-up status regarding reoperation and survival of 291
operative survivors after surgery for acute type A aortic dissection.
Fig 2. Kaplan-Meier analysis shows estimate (solid line) of actu-
arial long-term survival for all patients with the with 95% conﬁ-
dence limits (CLs) (grey shaded area).
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both, to be candidates for reoperation. None of these
patients were offered a reoperation. Six (35%) sustained an
aortic rupture and died before coming to surgical treat-
ment, all of these occurring in a part of the aorta distal to
the operated-on segment. Finally, the circumstances were
unknown in one patient (6%). Overall, the cause of death in
10 patients (59%) was conﬁrmed by autopsy or they diedin-hospital; in the remainder, the death certiﬁcate was used.
The median largest aortic diameter at latest radiologic
follow-up (data from 12 patients) was 6.0 cm (range, 4.8-
10.0 cm). Fifteen (88%) had a DeBakey type I dissection.
Predictors of late death. In univariate analysis by log-
rank test, several variables were signiﬁcantly related to late
all-cause mortality: male sex (P ¼ .0022), increased age
(P < .0005), operation before 2005 (P ¼ .015), hemiarch
replacement (P ¼ .0021), hypothermic circulatory arrest
(P ¼ .033), respiratory failure (P < .0005), and permanent
neurologic damage (P < .0005). Several of these remained
independently related to late all-cause mortality in the
multivariable Cox regression analysis (Table III).
Late reoperation. Thirty-four patients underwent 46
reoperations, comprising 21 on the proximal aorta and 25
on the distal aorta (excluding reoperations unrelated to
the aorta, its side branches, or the initial operation). Reoper-
ation was performed after a median of 2.4 years (range 17
days-19 years). Indications for the 21 proximal reopera-
tions included 11 (52%) for pseudoaneurysm, anastomotic
insufﬁciency in proximal, or distal suture line, or a combi-
nation of these; eight (38%) for aortic root dilatation, with
or without concomitant aortic regurgitation (one with
concomitant mitral valve regurgitation); one (4.8%) for right
common carotid artery bypass due to dynamic obstruction,
and one for fungal prosthetic valve endocarditis. No patients
reoperated on for aortic root dilatation or aortic regurgita-
tion had a documented bicuspid aortic valve.
Table II. Cause of late mortality
Variable No. (%)
Aortic 23 (27)a
Cardiac 21 (24)
Malignancy 9 (10)
Infection 8 (9.3)
Cerebrovascular 7 (8.1)
Pulmonary 2 (2.3)
Other 3 (3.5)
Unknown/missing 13 (15)
Total 86 (100)
aIncluding two intraoperative deaths due to bleeding at late reoperation.
Table III. Multivariable Cox analysis of variables related
to long-term all-cause mortality
Variable HR (95% CL) P
Age, 10-year increment 1.63 (1.34, 1.97) <.0005
Operation before 2005 2.32 (1.16, 4.64) .017
Permanent neurologic damage 2.58 (1.57, 4.25) <.0005
Respiratory failure 3.43 (1.84, 6.39) <.0005
CL, Conﬁdence limits; HR, hazard ratio.
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supracoronary graft, ﬁve (24%) had a composite graft, and
one (5%) had a separate valve and supracoronary graft.
Overall, 15 of 201 (8%) with a supracoronary graft replace-
ment underwent a proximal reoperation compared with
ﬁve of 86 (6%) with composite graft and one of four
(25%) with valve and graft (P ¼ .34). The indication for
the 25 distal reoperations was aortic dilatation engaging
the descending aorta in 12 (48%), the aortic arch in nine
(36%; in six managed with a concomitant elephant trunk),
the thoracoabdominal aorta in two (8%) and the infrarenal
aorta in one (4%). The distal reoperation was more
common in DeBakey type I than in type II dissection
(9% vs 0.8%; P ¼ .0024).
Twelve patients (35% of those reoperated-on) under-
went multiple reoperations, as detailed in Table IV. The
primary operation in eight was a simple supracoronary graft
repair with open distal anastomosis not including the arch.
For those undergoing distal reoperations, an elective,
staged approach, including total arch replacement (with
or without elephant trunk extension), followed by
descending aortic repair, was carried out in six of ten. Over-
all, the Kaplan-Meier estimated (SE) freedom from aortic
reoperation at 1, 5, 10, and 15 years was, respectively, 99
(1%), 95% (2%), 87% (4%), and 61% (5%). The 30-day
mortality for reoperations was six of 46 (13%). Three
patients died late during follow-up, and median survival
after any reoperation was 3.2 years. Reoperation-related
in-hospital mortality is detailed in Table V.
Predictors of late reoperation. In univariate analysis
by log-rank test, use of gelatin-resorcinol-formaldehyde
(GRF) glue (P ¼ .0018) and temporary neurologicdamage (P ¼ .020) were related to the risk of proximal
reoperation. These variables remained signiﬁcant in multi-
variable Cox regression analysis (Table VI). GRF glue was
used in 12 of 21 patients (57%) later undergoing proximal
reoperation and in seven of 11 patients (64%) reoperated
on due to pseudoaneurysm formation. Overall, 14 of 92
patients (15%) operated on with the aid of GRF underwent
subsequent proximal reoperation. Being an iatrogenic
cause of reoperation, proximal reoperation was also
analyzed after excluding patients in whom GRF glue was
used. In the remaining 200 patients, Penn class Abc
emerged as the only independent predictor, with a HR
(95% CL) of 10.2 (1.9, 56). Excluding GRF-treated
patients did not alter the ﬁndings of multivariable analysis
for overall mortality, aortic mortality, or distal reoperation.
For distal reoperation, De Bakey type I dissection (P ¼
.0071), reoperation for infection (P ¼ .0332), and male sex
(P ¼ .049) were signiﬁcant in univariate analysis. DeBakey
type I dissection remained signiﬁcant in multivariable Cox
regression (Table VI). The only patient without DeBakey
type I dissection requiring distal reoperation underwent a total
arch replacement as a remedy for distal suture line insufﬁ-
ciency causing an arch pseudoaneurysm. Of the 16 patients
undergoing distal aortic reoperation, 15 were men and
none had prior hemiarch or total arch replacement (P¼ .08).
Marfan syndrome. Eight patients had Marfan
syndrome. Six (75%) presented with DeBakey type I dissec-
tion. Seven (88%) underwent aortic root replacement using
a mechanical composite graft; one redo patient already had
a composite graft implanted. In none was a hemiarch or
total arch replacement performed. One (13%) early and
one late death occurred, in both instances as a result of
aortic events. Of the remaining six patients, three (50%)
underwent late reoperationdall with DeBakey type I
dissection, all on the descending aortadafter an interval
of 7 to 19 years and without operative mortality. Two of
these eventually underwent a second redo with replace-
ment of the remaining thoracoabdominal aorta, also
without operative death (Table IV).
DISCUSSION
Emanating from our previously reported6 cohort of
360 consecutive patients operated on for acute type
A dissection, this is one of the most extensive follow-
up studies to date, including 291 operative survivors moni-
tored for a median of 5.5 years, totaling 1864 patient-years,
and including 132 events (late deaths and reoperations;
Fig 1). The long-term survival in this study, estimated
at 64% after 10 years and 48% after 15 years (Fig 2),
was comparable to that of other studies5,7-10 and
re-emphasizes the impaired survival outlook compared
with a healthy population.1,2
Variables independently related to late all-cause
mortality, including age, permanent neurologic damage,
respiratory insufﬁciency, and operation during an earlier
period (<2005), are consistent with previous reports.7-12
Increased age was a predictor of overall mortality, whereas
younger age was a predictor of aortic-related mortality.
Table IV. Patient characteristics and procedures in cases of multiple late reoperations
Pt No. Sex Age,ayears Primary operation Time elapsed First reoperation Time elapsed
Second
reoperation Survivalb
13 M 68 SCG, ODA 1.9 years TAR 2.5 months DTA 10.4 years; alive
46 M 52 Comp, AXC 5.6 years TARþET 4.5 years DTA 5.8 years; alive
63 M 61 Comp, ODA 2.8 years TARþET 3 months DTA 1.9 years; alive
67 M 60 SCG, ODA 3.6 years TARþET 10 months DTA 4 months; alive
69 M 59 SCG, ODA 2.5 years TARþET 3 months DTA 1.8 years; alive
80 M 54 SCG, ODA 17 days RCCA bypass 6.5 years DTA 3 months; alive
86 M 50 SCG, ODA 2.4 years Comp 5 years Pseudo 1.5 years; alive
98 M 43 Comp, ODA 8.4 years DTA 1.1 years TAAA 1.1 years; alive
99 F 34 Comp, ODA 19 years DTA 3 months TAAA 1 months; alive
104 M 40 SCG, ODA 6.4 years TARþET 3 months DTA 1.7 years; alive
188 M 58 SCG, ODA 1.7 years Comp 3.5 years TAR 0; dead
355 F 59 SCG, ODA 1.4 years Comp 2.3 years Pseudo 4.9 years; dead
AXC, Aortic cross-clamp; Comp, composite graft; DTA, descending thoracic aortic repair; ET, elephant trunk; F, female; M, male; ODA, open distal anas-
tomosis; Pseudo, pseudoaneurysm; Pt, patient; RCCA, right common carotid artery; SCG, supracoronary graft; TAAA, thoracoabdominal aortic aneurysm
repair; TAR, total arch replacement.
aAge at primary operation.
bSurvival from latest reoperation until, and status at, time of cross-sectional follow-up.
Table V. In-hospital mortality associated with aortic reoperation and possibility of catheter-based or hybrid intervention
Pt No. Sex Age, years Indication Surgical procedure Outcome Possible alternative intervention
166 F 66 Aortic root dilatation þ aortic
regurgitation
Composite graft IOD None
185 M 70 Arch and descending aortic dilatation TAR þ ET Death POD 13 Hybrid arch repair
188 M 63 Distal anastomotic pseudoaneurysm TAR IOD Hybrid arch repair; percutaneous
device closure
231 M 72 Arch and descending aortic dilatation DTA IOD Hybrid arch repair; TEVAR
242 M 75 Distal anastomotic pseudoaneurysm Aneurysm repair Death POD 19 Hybrid repair; percutaneous
device closure
303 M 48 Fungal prosthetic valve endocarditis Composite graft Death POD 7 None
DTA, Descending thoracic aortic repair; ET, elephant trunk; F, female; IOD, intraoperative death; M, male; POD, postoperative day; Pt, patient; TAR, total
arch replacement; TEVAR, thoracic endovascular aortic repair.
Table VI. Multivariable Cox analysis of variables related
to proximal and distal reoperation
Variable HR (95% CL) P
Proximal reoperation
Use of surgical adhesive 4.17 (1.58, 11.0) .004
Temporary neurological damage 3.24 (1.18. 8.93) .023
Distal reoperation
DeBakey type I dissection 10.5 (1.38, 80) .023
CL, Conﬁdence limits; HR, hazard ratio.
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natural effect of age on mortality on one hand, and on the
other the fact that any condition causing death in young
individuals would appear signiﬁcant given their very low
background mortality rate. The ﬁndings underscore the
sobering fact that operative techniques and perioperatively
modiﬁable variables do not perceivably inﬂuence late
mortalityda strong incentive for developing novel treat-
ment approaches. The cause of late death was aorta-
related in at least 27, up to 42%, including those withunknown cause of death (Table II). Reducing late aortic
complications, including reoperation-related mortality,
would contribute to an improved long-term prognosis.
Overall, 46 late reoperations were undertaken in 34
patients (12%) up to 19 years after the primary procedure,
and 12 underwent two reoperations. The estimated
freedom from any reoperation was 87% at 10 years and
61% at 15 years, also equivalent to previous reports.7-12
Reoperation rate is biased by institutional attitudes, given
a substantial risk of mortality and morbidity; in this study,
in-hospital mortality was 14% for proximal reoperations
and 12% for distal reoperations (Fig 1), and was reported
as high as 30% for distal reoperations.5
The use of GRF glue to adapt and reinforce aortic wall
layers was associated with an increased risk of late proximal
reoperation, and in 64% was related to suture-line pseudoa-
neurysm formation. This is a recurring, but not universal or
undisputed, ﬁnding from other studies,13,14 suggesting
judicious patient selection and glue application, respec-
tively. We have abandoned the use of GRF glue.
In statistical analysis, Marfan syndrome was not inde-
pendently related to late reoperation, but the small patient
JOURNAL OF VASCULAR SURGERY
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and in fact, 50% of long-term survivors with Marfan
syndrome did undergo late (distal) reoperation. These
patients also had a high prevalence of DeBakey type I dissec-
tion, self-evidently related to the risk of late distal reopera-
tion (Table VI) given the extent of aortic wall damage.
Interestingly, yet again not statistically signiﬁcant,
hemiarch or total arch replacement at the primary opera-
tion entailed no late distal reoperations, corroborating
recent ﬁndings.15 The decision to perform more extensive
surgery at the primary acute operation is certainly better
justiﬁed if conveying a decreased risk of subsequent proce-
dures on the aortic arch and downstream.
A stagnating development of nonimproving surgical
results unfolding during the recent decades8,16 is paral-
leled by a signiﬁcant and promising development of less
invasive treatment modalities comprising percutaneous,
endovascular, and hybrid interventions. There are implica-
tions for endovascular and related interventions to the
growing cohort of patients surviving acute type A dissec-
tion surgery:
First, already at the primary operation, the develop-
ment of the so-called frozen elephant trunk, using
a composite stent graft/vascular graft device delivered
antegradely through the opened aortic arch, shows very
promising results, with very low (4.6%-4.7%) intraoperative
mortality, almost abolished need for distal reintervention
(0.5%-2.5%), and an accordingly high (92%-95%) false
lumen obliteration at midterm follow-up.17,18 If an indica-
tion for a distal reintervention does occur, the frozen
elephant trunk paves the way for continued endovascular
repair of the descending or thoracoabdominal aorta.
Downstream from the aorta, in analogy, an endovascular
or even open surgical repair of the descending aortad
recently shown not to carry unduly high risk related to
the chronic dissection per se19,20dmay transform
a higher-risk thoracoabdominal aortic aneurysm type I or
II into a lower-risk21 type III or IV, at the same time
accomplishing two desirable goals: reduced risk of para-
plegia from staging the intervention (0% vs 15% in exten-
sive single-stage procedures)22 and, again, regularly
creating a suitable proximal landing zone for further endo-
vascular repair if indicated.
Second, importantly, the present and previous
studies4-5,12 report no use of late endovascular (re)inter-
ventions in these patients, suggesting underutilization of
this important treatment modality and departing from
the approach to treat primary type B dissection using endo-
vascular techniques.23 Patients arguably considered ex-
cluded from endovascular aortic repair include those with
pathology of the aortic root or valve, or both, Marfan syn-
drome,24 infected vascular prosthesisdalthough conceiv-
able when surgical risk is deemed prohibitive.25 In other
situations, treating progressive or recurrent aortic pa-
thology of the arch, descending, or thoracoabdominal
aorta, as well as favorably localized postoperative pseudoa-
neurysms, catheter-based repair can be an attractive remedy
to complex or high-risk problems.21Applying such principles to the patient cohort in this
study, 12 of 21 proximal and 22 of 25 distal reoperations
(74% of all reoperations) could have been eligible for
catheter-based or hybrid intervention: four of the six opera-
tions (66%) entailing surgical mortality were potentially
amenable to catheter-based therapy (Table V). Patients
suffering aortic-related death were often (59%) not consid-
ered for reoperation regardless of aortic diameter (in this
group, median, 6.0 cm; max, 10.0 cm) or ruptured unex-
pectedly (32%) despite surveillance, always in the distal aorta.
Endovascular or hybrid treatment is often considered
a suitable choice for old or fragile patients and should be
contemplated in situations where an indication for inter-
vention is reasonable but open reoperation is not. Most
of these patients died before the introduction of catheter-
based aortic repair, which helps to explain why no patient
was offered such treatment in this series. The point,
however, is that with the development of catheter-based
aortic repair, more acute type A dissection survivors may
be considered for reintervention.
Increased aortic diameter also confers worse surgical
results in this patient population,25 supporting the more
liberal treatment indications (5.5-cm aortic diameter in
the descending aorta) established in recent guidelines26
and suggesting even more possible candidates for open or
endovascular repair. For reasons stated above, chronic
residual dissection present in patients after being operated
on for acute DeBakey type I dissection will behave differ-
ently from the relatively benign course of uncomplicated
type B (DeBakey type III) dissection, hitherto not shown
to beneﬁt from prophylactic endovascular treatment.27
This study has some limitations. In this retrospective
follow-up study, with inherent study design weaknesses,
treatment was not randomly assigned and varied over
time. Several putatively important variables related to late
mortality and reoperation were not studied, including exact
localization of intimal tear(s), whether the tear(s) was
completely resected, the precise extent of dissection apart
from DeBakey type, coronary artery disease, left ventricular
ejection fraction, and renal and respiratory failure of other
degrees than those entailing dialysis and tracheostomy.
CONCLUSIONS
Reduction of late mortality rates, avoidance of unnec-
essary (primarily aorta-related) deaths, and timely detection
of the often asymptomatic changes in the operated-on or
residual aorta qualifying for reoperation or reintervention
are still needed. Vigilant radiologic and clinical follow-up
is necessary for as long as a patient can be considered
a reasonable candidate for an open surgical reoperation
or a catheter-based reintervention.26 This is demonstrated
by the indeﬁnite attrition rate (linearized late mortality of
5% per patient-year), the proportion of late aorta-related
deaths (27%-42%), and the need for late reoperation even
very remote (up to 19 years) from the primary operation.
Obvious in DeBakey type I dissection, we, as opposed to
others,15 would also argue for similar follow-up of patients
with DeBakey type II dissection, not because of the risk of
JOURNAL OF VASCULAR SURGERY
Volume 58, Number 2 Olsson et al 339late distal disease but because of the apparent risk of late
surgical failure manifested as anastomotic leakage and pseu-
doaneurysm formation, especially if GFR glue was used
primarily. Novel approaches, including hybrid and
catheter-based treatment, primarily or in combating late
aortic sequelae, may contribute to improved early and
late survival and expand treatment indications to patients
previously considered at too high a surgical risk; here,
some 59% of patients suffering aortic-related death.
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List of variables and deﬁnitions used in univariable and
multivariable statistical analysis
Sex (male/female)
Age (years): grouped by decade #39, 40-49, 50-59,
60-69, 70-79, $80 years
Family history (yes/no): known family history of aortic
aneurysm or dissection, or both
Marfan syndrome (yes/no)
Obesity (yes/no): Body mass index $35 kg/m2
Diabetes (yes/no): requiring medical treatment
Chronic obstructive pulmonary disease (yes/no): requiring
medical treatment
Hypertension (yes/no): requiring medical treatment or
diagnosed at admission
Smoking history (yes/no): current or past smoking
CVI history (yes/no): veriﬁed cerebrovascular incident
with or without current sequelae
Redo operation (yes/no): Previous open heart surgery
requiring median sternotomy
DeBakey type I dissection (yes/no)
Early era (yes/no): operation before 2005 vs 2005 through
2009
Bicuspid aortic valve (yes/no): known or diagnosed perio
peratively
Aortic regurgitation (yes/no): known or diagnosed perio
peratively
Grade of aortic regurgitation (I-IV): mild (grade I);
moderate (grade II); severe (grade III-IV)
Shock (yes/no): any of hypotension <90 mm Hg,
inotropic support, pulmonary edema, anuria or oliguria
Penn Class (Aa/Ab/Ac/Abc/non-Aa): Aa, no end-organ
ischemia; Ab, localized ischemia (upper/lower
extremity, central nervous system, renal, mesenteric); Ac,
generalized ischemia or dissection-related coronary
ischemia producing general ischemia, or both; Abc,
localized and generalized ischemia; Non-Aa, any Penn
class other than Aa
Tamponade (yes/no): as diagnosed perioperatively
Supracoronary graft (yes/no): tube graft with proximal
suture line at the level of the sinotubular junction
Composite graft (yes/no): mechanical valved graft with
reimplantation of coronary artery ostia
Separate valve þ graft (yes/no): prosthetic valve replace
ment with concomitant supracoronary graftHemiarch replacement (yes/no): open distal anastomosis
including resection of the minor curvature
Total arch replacement (yes/no): arch replacement with
cervical vessel reimplantation with or without elephant
trunk
Aortic valve resuspension (yes/no): suture with or without
glue used to resuspend or reattach the aortic valve
Gelatin-resorcinol-formaldehyde glue (yes/no): Glue used
to adapt aortic wall layers
Coronary artery bypass grafting (yes/no)
Hypothermic circulatory arrest (yes/no)
Hypothermic circulatory arrest time (minutes)
Aortic cross-clamp time (minutes)
Cardiopulmonary bypass time (minutes)
Cerebral perfusion (yes/no): retrograde or antegrade vs no
cerebral perfusion
Retrograde cerebral perfusion (yes/no)
Antegrade cerebral perfusion (yes/no)
Femoral artery cannulation (yes/no)
Axillary artery cannulation (yes/no)
Reexploration for bleeding (yes/no): requiring resternotomy
Reexploration for infection (yes/no): requiring resternotomy
Renal failure (yes/no): requiring hemoﬁltration or
hemodialysis
Respiratory failure (yes/no): requiring tracheostomy
Temporary neurologic deﬁcit (yes/no): symptom(s)
resolving during hospitalization
Permanent neurologic deﬁcit (yes/no): symptom(s) not
resolving during hospitalization
Proximal reoperation: reoperation on previously operated
part(s) of the aorta including the aortic valve and root
Distal reoperation: reoperation on not previously operated
part(s) of the aorta distal to the initial operation
Late death: death occurring after hospital discharge
Cause of death
Aortic, due to aortic rupture, dissection, repeat dissec-
tion or aortic reoperation
Cardiac, due to myocardial infarction, heart failure, or
arrhythmia
Pulmonary, due to respiratory insufﬁciency
Cerebrovascular, due to cerebrovascular insult
(embolic or hemorrhagic)
Infectious
Malignancy
Other, due to other known condition
Unknown
